Related Articles
Immunohistochemical analysis of BRCA2 expression in normal human buccal cells.
An antibody assay predictive of BRCA1 mutations in ovarian tumors and normal tissue.
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report
Immunohistochemical analysis of BRCA1 expression in normal human buccal cells.